Abstract
The in vivo occurrence of apoptosis in neuroblastomas was investigated. Histologically, a number of tumour cells showed typical apoptotic changes, including cell shrinkage, condensed and fragmented nuclei, eosinophilic cytoplasm, and absence of the inflammatory response. These cells coincided closely with the so-called karyorrhectic cells. An electrophoretic DNA ladder, a functional hallmark of apoptosis, was demonstrated in four of six tumours, and DNA fragmentation was detected in situ by terminal deoxytransferase-mediated nick end-labelling in 26 of 35 tumour specimens (74%). The labelled cell counts ranged from 5 to 62 per 5000 tumour cells (mean±SD: 15.0±14.5). Immunoperoxidase staining revealed that an apoptosis-suppressing protein, bcl-2, was expressed abundantly in advanced-stage tumours, whereas it was absent from karyorrhectic-apoptotic cells. Several tumours with the potential for spontaneous regression were bcl-2-deficient. Immunostaining of the Fas receptor for apoptosis demonstrated that the tumour cells expressed this molecule on their cell surfaces. Our results provide evidence of apoptosis in neuroblastomas and suggest that bcl-2 and the Fas receptor may play a role in its regulatory mechanisms.
Similar content being viewed by others
References
Arends MJ, Wyllie AH (1991) Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 32:223–254
Arends MJ, Morris RG, Wyllie AH (1990) Apoptosis: the role of the endonuclease. Am J Pathol 136:593–608
Arends MJ, McGregor AH, Wyllie AH (1994) Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes. Am J Pathol 144:1045–1057
Baak JPA (1990) Mitosis counting in tumors. Hum Pathol 21:683–685
Bolande RP (1991) The spontaneous regression of neuroblastoma: experimental evidence for a natural host immunity. Pathol Annu 26:187–199
Carson DA, Ribeiro JM (1993) Apoptosis and disease. Lancet 341:1251–1254
Cassady JR (1990) Prognostic factors affecting the outcome of children with neuroblastoma. In: Pochedly C (eds) Neuroblastoma: tumor biology and therapy. CRC Press, Boca Raton, Fla, pp 369–379
Castle PC, Heidelberger KP, Bromberg J, Qu X, Dole M, Nuñez G (1993) Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543–1550
Cohen JJ, Duke RC (1984) Glucocorticoid activation of a calcium-dependent endonucease in thymocyte nuclei leads to cell death. J Immunol 132:38–42
D'Angio GJ, Evans AE, Koop CE (1971) Special problem of widespread neuroblastoma with a favourable prognosis. Lancet I:1046–1049
Evans AE, D'Angio GJ, Randolph J (1971) A proposed staging for children with neuroblastoma. Cancer 27:374–378
Fukasaka Y, Ishikawa H, Takeda A, Yokoyama S, Imamura M, Yoshiki T, Sato H (1994) Massive apoptosis in infantile myofibromatosis. A putative mechanism of tumor regression. Am J Pathol 144:480–485
Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501
Hockenbery D, Nunez G, Millman C, Schreiber RD, Korsmeyer SJ (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature : 334–336
Ikeda Y, Lister J, Buyukpamukcu M (1981) Congenital neuroblastoma in situ, and the normal fetal development of adrenal. J Pediatr Surg : 36–644
Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243
Jensen LM, Zhang Y, Shooter EM (1992) Steady-state polypeptide modulations associated with nerve growth factor (NGF)-induced terminal differentiation and NGF deprivation-induced apoptosis in human neuroblastoma cells. J Biol Chem 267:19325–19333
Joshi VV, Cantor AB, Altshuler G, Larkin EW, Neil JSA, Shuster JJ, Holbrook CT, Hayes FA, Nitschke R, Duncan MH, Shochat SJ, Talbert J, Smith EI, Castleberry RP (1992) Age-linked prognostic categorization based on a new histologic grading system of neuroblastoma: a clinicopathologic study of 211 cases from the Pediatric Oncology Group. Cancer 69:2197–2211
Kayashima K, Ono T, Johnao M, Kojo Y, Yamashita N, Matsunaga W (1991) Spontaneous regression in Merkel cell (neuroendocrine) carcinoma of the skin. Arch Dermatol 127:550–553
Kerr JFR, Wyllie AH, Currie AR (1972) A basic biological phenomenon with wide ranging implication in tissue kinetics. Br J Cancer 26:239–257
Kerr JFR, Winterfold CM, Harmon BV (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73:2013–2026
Manjo G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol : 3–15:
Matsumura M, Tsunoda A, Nishi T, Nishihira H, Sasaki Y (1991) Spontaneous regression of neuroblastoma detected by mass screening. Lancet 338:447–448
Nakagawa-Yagi Y (1994) Induction of apoptotic cell death in differentiating neuroblastoma SH-SY5Y cells by colchicine. Biochem Biophys Res Commun 199:807–817
Ninane J, Pritchard J, Morris-Jones P, Mann JR, Malpas JS (1982) Stage II neuroblastoma: adverse prognostic significance of lymph node involvement. Arch Dis Child 57:438–442
Piacentini M, Fesus L, Farrace MG, Ghibelli L, Piredda L, Melino G (1991) The expression of “tissue” transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol 54:246–254
Piacentini M, Fesus L, Melino G (1993) Multiple cell cycle access to the apoptotic death programme in human neuroblastoma cells. FEBS Lett 320:150–154
Pritchard J, Hickman JA (1994) Why does stage 4s neuroblastoma regress spontaneously? Lancet 344:869–870
Rabizadeh S, Oh J, Zhong L, Yang J, Bitler CM, Butcher LL, Bredesen DE (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261:345–348
Ramani P, Lu Q-L (1994) Expression of bcl-2 gene product in neurobolastoma. J Pathol (Lond) 172:273–278
Sambrook J, Frittsch EF, Maniatis T (1989) Molecular cloning, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Sawada T (1992) Past and future of neuroblastoma screening in Japan. Am J Pediatr Hematol Oncol 14:320–326
Searle J, Kerr JFR, Bishop CJ (1982) Necrosis and apoptosis: distinct modes of cell death with fundamentally different significance. Pathol Annu 17:229–259
Shimada H (1992) Neuroblastoma. Pathology and biology. Acta Pathol Jpn 42:229–241
Shimada H, Chatten J, Newton WAJ, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classificaion of neuroblastomas. JNCI 73:405–416
Stage D, De-Geeter G (1992) Rhabdomyomes cadaques et apoptose: les regressions sont-elles controlées par l'organisme? Arch Mal Coeur Vaiss 85:603–608
Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M, Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301–305
Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65:1097–1098
Wyllie AH, Morris RG, Smith AL, Dunlop D (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (Lond) 142:67–77
Young JL, Ries LG, Silverberg E, Horm JW, Miller RW (1986) Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58:598–602
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Koizumi, H., Takakuwa, T., Uchikoshi, T. et al. Demonstration of apoptosis in neuroblastoma and its relationship to tumour regression. Vichows Archiv A Pathol Anat 427, 167–173 (1995). https://doi.org/10.1007/BF00196522
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00196522